J&J's strong quarter was amplified by new details around its big Kenvue consumer unit stake

Johnson & Johnson's management updated their thoughts on how to handle the company's 89.6% interest in Kenvue.

from Health and Science https://ift.tt/206o87h
https://ift.tt/0VFr16e
https://ift.tt/zuwyn7L